Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), and Civica, Inc. (Civica), a not-for-profit generic drug and ...

The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received ...

The company also received tentative FDA approval for its ANDA for Rivaroxaban, an anticoagulant used to treat deep vein ...

Dasatinib is prescribed for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML) in adults.

Siddharth Mittal, MD and CEO of Biocon said the company will launch Liraglutide in Europe in FY26 along with its partner, ...

Biocon Ltd is quoting at Rs 320.8, up 1.91% on the day as on 12:49 IST on the NSE. The stock is up 16.87% in last one year as compared to a 0.46% slide in NIFTY and a 4.57% slide in the Nifty Pharma ...

Stocks like Ola Electric Mobility, Grasim Industries, RHI Magnesita India, Apollo Hospitals Enterprise, Walchandnagar ...

Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.

BRIDGEWATER, N.J. and BENGALURU, India, Feb. 24, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code ...

Biocon Foundation marks 20 years of transforming lives with slew of healthcare initiatives: Our Bureau, Bengaluru Tuesday, March 4, 2025, 14:15 Hrs [IST] Biocon Foundation, the Co ...